Cross-resistance associated with development of resistance to isometamidium in a clone of Trypanosoma congolense.

AUTOR(ES)

Peregrine, A S

RESUMO

Resistance to isometamidium was increased 94-fold in a clone of Trypanosoma congolense (clone IL 1180) by repeated subcurative treatment of infected mice for 11 months. This was associated with 3.4-, 33-, and 4.2-fold increases in resistance to diminazene, homidium, and quinapyramine, respectively. Both T. congolense IL 1180 and the resistant derivative were able to undergo cyclical development in Glossina morsitans centralis tsetse flies, producing hypopharyngeal infection rates of 40.0 and 39.8%, respectively.

Documentos Relacionados

• Derivation and characterization of a quinapyramine-resistant clone of Trypanosoma congolense.
• Cross-Resistance of Pseudomonas to Gentamicin and Tobramycin
• Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis
• Development of halofantrine resistance and determination of cross-resistance patterns in Plasmodium falciparum.
• Azole Cross-Resistance in Aspergillus fumigatus